Polonezii de la Polpharma cumpără Biofarm într-o tranzacție de 257 milioane de euro

Polpharma has acquired Biofarm for €257 million, enhancing its presence in the Romanian pharmaceutical market. This strategic move aims to integrate Biofarm's extensive product portfolio and local expertise into Polpharma's operations. The acquisition is expected to foster growth and innovation while maintaining Biofarm's identity and relationships. Key executives from Polpharma will join Biofarm's board to ensure a smooth transition and collaboration between teams. Biofarm, established in 1921, offers over 200 products across various therapeutic areas, reinforcing Polpharma's position in Central and Eastern Europe.